These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1100951)

  • 21. The treatment of tuberculosis and leprosy.
    Ellard GA
    Lepr Rev; 1975 Sep; 46(3):149-55. PubMed ID: 1102829
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
    Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concepts behind the development of multiple drug therapy regimens in leprosy.
    Waters MF
    Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437
    [No Abstract]   [Full Text] [Related]  

  • 24. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues.
    Dhople AM; Namba K
    Int J Antimicrob Agents; 2003 Mar; 21(3):251-5. PubMed ID: 12636987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapeutic trials in patients with non-lepromatous leprosy.
    Pearson JM
    Lepr Rev; 1975 Jun; 46(2 Suppl):63-5. PubMed ID: 1100965
    [No Abstract]   [Full Text] [Related]  

  • 27. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
    Ji B; Perani EG; Petinom C; Grosset JH
    Antimicrob Agents Chemother; 1996 Feb; 40(2):393-9. PubMed ID: 8834886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae.
    Sapkota BR; Ranjit C; Macdonald M
    Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leprosy.
    Marcos LA; Conerly S; Walker S
    Am J Trop Med Hyg; 2014 Aug; 91(2):216. PubMed ID: 25100789
    [No Abstract]   [Full Text] [Related]  

  • 30. Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the people's Republic of China.
    Yu M; Wu K; Pei B; Yang D; Wang Q; Wang H; Shen J; Yan L; Zhang G
    Clin Interv Aging; 2013; 8():1097-9. PubMed ID: 23986632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent trends in chemotherapy of leprosy.
    Parikh DA; Maniar JK; Parikh AC; Ganapati R
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
    Sansarricq H
    Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
    [No Abstract]   [Full Text] [Related]  

  • 33. Multi-drug therapy of leprosy.
    Ramu G
    Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple mutations in the rpoB gene of Mycobacterium leprae strains from leprosy patients in Thailand.
    Ramasoota P; Wongwit W; Sampunachot P; Unnarat K; Ngamying M; Svenson SB
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):493-7. PubMed ID: 11289008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifampicin for lepromatous leprosy: nine years' experience.
    Waters MF; Rees RJ; Pearson JM; Laing AB; Helmy HS; Gelber RH
    Br Med J; 1978 Jan; 1(6106):133-6. PubMed ID: 339995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer drugs in leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single dose multidrug therapy for single lesion paucibacillry leprosy.
    Salafia A
    Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
    [No Abstract]   [Full Text] [Related]  

  • 38. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five?
    Kumarasinghe SP; Kumarasinghe MP
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583
    [No Abstract]   [Full Text] [Related]  

  • 39. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 40. Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India.
    Lavania M; Nigam A; Turankar RP; Singh I; Gupta P; Kumar S; Sengupta U; John AS
    Clin Microbiol Infect; 2015 Dec; 21(12):e85-6. PubMed ID: 26314915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.